Researchers analyze the mutational landscape of TMB-high colorectal cancer tumors
Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes ...
Tag: Carcinoma
Waist circumference identified as a stronger cancer risk marker in men
Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of ...
Lifelong weight patterns linked to kidney cancer risk
Excess weight in mid-life is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout ...
Adding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patients
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following ...
Unraveling the genetic differences between LUAD and LUSC in lung cancer
Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma ...
Study uncovers pathway behind age-related degeneration of eye glands
A team led by Mount Sinai researchers has identified stem cell populations and mechanisms underlying age-related degeneration in glands that ...
New insights into rare liver cancer as clinical trial for treatment begins
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
Study reveals how fatty liver disease leads to liver cancer
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...
Exploring new ways to improve treatment options for kidney cancer patients
A Medical University of South Carolina Hollings Cancer Center researcher is exploring new ways to improve treatment options for kidney cancer ...
Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...